Federal Register / Vol. 78, No. 27 / Friday, February 8, 2013 / Notices 9405 

Sciences and Epidemiology: Member Conflict 

Applications. 

Date: March 4–5, 2013. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Karin F Helmers, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3166, 

MSC 7770, Bethesda, MD 20892, 301–254– 

9975, helmersk@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel;Population 

Sciences and Epidemiology: Member Conflict 

Applications 

Date: March 4–5, 2013. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Karin F Helmers, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3166, 

MSC 7770, Bethesda, MD 20892, 301–254– 

9975, helmersk@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–10– 

244: The Collaborative Genetic Study of 

Nicotine Dependence. 

Date: March 5–6, 2013. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting) 

Contact Person: Eugene Carstea, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5194, 

MSC 7846, Bethesda, MD 20892, (301) 408– 

9756, carsteae@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

Development of Appropriate Pediatric 

Formulations and Pediatric Drug Delivery 

System. 

Date: March 5, 2013. 

Time: 1:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Robert C Elliott, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3130, 

MSC 7850, Bethesda, MD 20892, 301–435– 

3009, elliotro@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Program 

Project: NanoImaging Center. 

Date: March 5–7, 2013. 

Time: 6:00 p.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

Contact Person: Joseph Thomas Peterson, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4118, 

MSC 7814, Bethesda, MD 20892, 301–408– 

9694, petersonjt@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846- 93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: February 4, 2013. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2013–02840 Filed 2–7–13; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Agency Information Collection 

Activities: Request for Expressions of 

Interest (EOI) To Perform a Chemical 

Defense Demonstration Project 

AGENCY: Office of Health Affairs 

Chemical Defense Program, DHS. 

ACTION: 60-Day Notice and request for 

comments; New Collection, 1601— 

NEW. 

SUMMARY: The Department of Homeland 

Security, Office of Health Affairs 

Chemical Defense Program, will submit 

the following Information Collection 

Request (ICR) to the Office of 

Management and Budget (OMB) for 

review and clearance in accordance 

with the Paperwork Reduction Act of 

1995 (Pub. L. 104–13, 44 U.S.C. Chapter 

35). 

DATES: Comments are encouraged and 

will be accepted until April 9, 2013. 

This process is conducted in accordance 

with 5 CFR 1320.1. 

ADDRESSES: Written comments and 

questions about this Information 

Collection Request should be forwarded 

to Office of Health Affairs Chemical 

Defense Program, DHS, Attn.: CAPT 

Joselito Ignacio, 

joselito.ignacio@hq.dhs.gov, 202–254– 

5738. 

SUPPLEMENTARY INFORMATION: The 

Chemical Defense Program seeks to 

obtain information from respondents 

interested in hosting a demonstration 

project aimed at developing a 

comprehensive chemical defense 

framework. The authority for the 

Chemical Defense Program to collect 

this information can be found in Public 

Law 112–74, Consolidated 

Appropriations Act, 2012 and 

Conference Report 112–331. 

The information requested on the 

form includes: name of state, local, 

tribal, or territorial government agency; 

address; submitter’s name, position and 

contact information; identified venue 

for demonstration project; interest in 

developing a chemical defense 

capability; specific reasons for the 

communities interest and needs for a 

chemical defense capability; community 

chemical threat assessed risks if 

applicable; any additional information 

respondent requests for consideration. 

As identified in Public Law 112–74 and 

Conference Report 112–331, the 

Chemical Defense Program must 

competitively select the locations for 

conducting the chemical defense 

demonstration projects. The Chemical 

Defense Program will use the provided 

information for the selection process. 

The Office of Management and Budget 

is particularly interested in comments 

which: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses. 

Analysis 

Agency: Office of Health Affairs 

Chemical Defense Program, DHS. 

Title: Request for Expressions of 

Interest (EOI) To Perform a Chemical 

Defense Demonstration Project. 

OMB Number: 1601–NEW. 

Frequency: Once. 

Affected Public: State, Local, or Tribal 

Government. 

Number of Respondents: 25. 

Estimated Time Per Respondent: 20 

hours. 

Total Burden Hours: 500 Hours. 

Dated: January 29, 2013. 

Richard Spires, 

Chief Information Officer. 

[FR Doc. 2013–02886 Filed 2–7–13; 8:45 am] 

BILLING CODE 9110–9B–P 


sroberts on DSK5SPTVN1PROD with NOTICES